Alzheimer disease and platelets: how’s that relevant

[1]  J Carter,et al.  Molecular Pathology of Alzheimer's Disease , 2013 .

[2]  G. Ricevuti,et al.  Alzheimer disease and platelets: how’s that relevant , 2012, Immunity & Ageing.

[3]  Zhu-ying Huang,et al.  Effects of compound danshen tablets on spatial cognition and expression of brain beta-amyloid precursor protein in a rat model of Alzheimer's disease. , 2012, Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan.

[4]  L. Provinciali,et al.  Platelet Amyloid Precursor Protein Isoform Expression in Alzheimer's Disease: Evidence for Peripheral Marker , 2011, International journal of immunopathology and pharmacology.

[5]  C. Balduini,et al.  Calmodulin regulates the non-amyloidogenic metabolism of amyloid precursor protein in platelets. , 2011, Biochimica et biophysica acta.

[6]  E. Ross,et al.  Coated-platelet levels and progression from mild cognitive impairment to Alzheimer disease , 2011, Neurology.

[7]  E. Porcellini,et al.  Serum neutrophil gelatinase-B associated lipocalin (NGAL) levels in Down’s syndrome patients , 2010, Immunity & Ageing.

[8]  Wendy R. Sanhai,et al.  Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives , 2010, Nature Reviews Drug Discovery.

[9]  Harald Hampel,et al.  Biological markers of amyloid β-related mechanisms in Alzheimer's disease , 2010, Experimental Neurology.

[10]  T. Casoli,et al.  Peripheral inflammatory biomarkers of Alzheimer’s disease: the role of platelets , 2010, Biogerontology.

[11]  N. Pivac,et al.  Platelet serotonin concentration and monoamine oxidase type B activity in female patients in early, middle and late phase of Alzheimer's disease , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[12]  P. Lewczuk,et al.  Differential processing and secretion of Aβ peptides and sAPPα in human platelets is regulated by thrombin and prostaglandine 2 , 2009, Neurobiology of Aging.

[13]  M. Cooper,et al.  Platelet alpha- and beta-secretase activities: A preliminary study in normal human subjects. , 2009, Platelets.

[14]  F. Wouters,et al.  Neuroprotective Secreted Amyloid Precursor Protein Acts by Disrupting Amyloid Precursor Protein Dimers* , 2009, Journal of Biological Chemistry.

[15]  J. Jia,et al.  [Platelet function in patients with Alzheimer disease: analysis of 40 cases]. , 2009, Zhonghua yi xue za zhi.

[16]  D. Craig,et al.  A novel reciprocal and biphasic relationship between membrane cholesterol and β‐secretase activity in SH‐SY5Y cells and in human platelets , 2009, Journal of neurochemistry.

[17]  C. Adler,et al.  Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease , 2009, Alzheimer's & Dementia.

[18]  Chien-Huang Lin,et al.  Amyloid beta peptide-activated signal pathways in human platelets. , 2008, European journal of pharmacology.

[19]  J. Götz,et al.  Animal models of Alzheimer's disease and frontotemporal dementia , 2008, Nature Reviews Neuroscience.

[20]  P. Gil,et al.  Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease. , 2008, Immunology letters.

[21]  A. Baraba,et al.  Substituting dietary polyunsaturated fat with monounsaturated fat increases insulin sensitivity in cultured rat hepatocytes. , 2008, Collegium antropologicum.

[22]  D. Craig,et al.  Platelet β-secretase activity is increased in Alzheimer's disease , 2008, Neurobiology of Aging.

[23]  J. Sheu,et al.  Expression of amyloid beta peptide in human platelets: pivotal role of the phospholipase Cgamma2-protein kinase C pathway in platelet activation. , 2008, Pharmacological research.

[24]  L. Provinciali,et al.  Modifications of platelet from Alzheimer disease patients: A possible relation between membrane properties and NO metabolites , 2007, Neurobiology of Aging.

[25]  D. Selkoe,et al.  Aβ Oligomers – a decade of discovery , 2007, Journal of neurochemistry.

[26]  S. Ferreira,et al.  Structure and functions of the human amyloid precursor protein: The whole is more than the sum of its parts , 2007, Progress in Neurobiology.

[27]  J. Siuda,et al.  Platelet phospholipase A2 activity in patients with Alzheimer’s disease, vascular dementia and ischemic stroke , 2007, Journal of Neural Transmission.

[28]  E. Londos,et al.  Soluble adhesion molecules and angiotensin-converting enzyme in dementia , 2007, Neurobiology of Disease.

[29]  R. Deane,et al.  Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease. , 2007, Current Alzheimer research.

[30]  E. Ross,et al.  Coated-platelets correlate with disease progression in Alzheimer disease , 2007, Journal of Neurology.

[31]  C. Hong,et al.  Correlation between platelet amyloid precursor protein isoform ratio and cognition in Alzheimer's disease. , 2007, Journal of Alzheimer's disease : JAD.

[32]  G. Davı̀,et al.  Determinants of platelet activation in Alzheimer's disease , 2007, Neurobiology of Aging.

[33]  L. Tsai,et al.  p25/Cyclin-Dependent Kinase 5 Induces Production and Intraneuronal Accumulation of Amyloid β In Vivo , 2006, The Journal of Neuroscience.

[34]  Mark Bowlby,et al.  Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[35]  E. Ross,et al.  Coated-platelets retain amyloid precursor protein on their surface , 2006, Platelets.

[36]  R. Rosenberg,et al.  Platelet amyloid precursor protein processing: A bio-marker for Alzheimer's disease , 2006, Journal of the Neurological Sciences.

[37]  S. Orrenius,et al.  Apoptosis: a basic biological phenomenon with wide‐ranging implications in human disease , 2005, Journal of internal medicine.

[38]  Joseph E Italiano,et al.  The biogenesis of platelets from megakaryocyte proplatelets. , 2005, The Journal of clinical investigation.

[39]  T. Keränen,et al.  GABA and glutamate transporters are expressed in human platelets. , 2005, Brain research. Molecular brain research.

[40]  B. Strooper,et al.  Regulation of cholesterol and sphingomyelin metabolism by amyloid-β and presenilin , 2005, Nature Cell Biology.

[41]  G. Dale,et al.  REVIEW ARTICLE: Coated‐platelets: an emerging component of the procoagulant response , 2005, Journal of thrombosis and haemostasis : JTH.

[42]  D. Holtzman,et al.  The Bad Seed in Alzheimer’s Disease , 2005, Neuron.

[43]  D. Gambi,et al.  Expression and production of two selected beta-chemokines in peripheral blood mononuclear cells from patients with Alzheimer's disease , 2005, Experimental Gerontology.

[44]  C. Scavone,et al.  Oxidative state in platelets and erythrocytes in aging and Alzheimer's disease , 2005, Neurobiology of Aging.

[45]  E. Favale,et al.  Decrease of Serotonin Transporters in Blood Platelets after Epileptic Seizures , 2005, Neurochemical Research.

[46]  Kurt Bürki,et al.  Aβ is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis , 2004, Nature Neuroscience.

[47]  C. Masters,et al.  Increased β‐Secretase activity in cerebrospinal fluid of Alzheimer's disease subjects , 2004, Annals of neurology.

[48]  O. Forlenza,et al.  Platelet phospholipase A2 activity in Alzheimer’s disease and mild cognitive impairment , 2004, Journal of Neural Transmission.

[49]  Hong Wang,et al.  Procoagulant surface exposure and apoptosis in rabbit platelets: association with shortened survival and steady‐state senescence , 2004, Journal of thrombosis and haemostasis : JTH.

[50]  C Caltagirone,et al.  Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease , 2004, Neurology.

[51]  C. Caltagirone,et al.  Platelet amyloid precursor protein abnormalities in mild cognitive impairment predict conversion to dementia of Alzheimer type: a 2-year follow-up study. , 2003, Archives of neurology.

[52]  K. Ravid,et al.  Role of Apoptotic Processes in Platelet Biogenesis , 2003, Acta Haematologica.

[53]  Colin L Masters,et al.  Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets , 2003, Journal of neuroscience research.

[54]  M. Lagarde,et al.  Activation of p38 mitogen-activated protein kinase/cytosolic phospholipase A2 cascade in hydroperoxide-stressed platelets. , 2003, Free radical biology & medicine.

[55]  H. Hampel,et al.  β‐amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease , 2003 .

[56]  M. Racchi,et al.  The pharmacology of amyloid precursor protein processing , 2003, Experimental Gerontology.

[57]  L. Rozzini,et al.  Early stages of probable Alzheimer disease are associated with changes in platelet amyloid precursor protein forms , 2002, Neurological Sciences.

[58]  B. Hyman,et al.  Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. , 2002, Archives of neurology.

[59]  B. Zlokovic,et al.  Effect of endothelial cell polarity on beta-amyloid-induced migration of monocytes across normal and AD endothelium. , 2002, American journal of physiology. Cell physiology.

[60]  G. Evin,et al.  Biogenesis and metabolism of Alzheimer’s disease Aβ amyloid peptides , 2002, Peptides.

[61]  I. Palomo,et al.  Platelet Aging In Vivo Is Associated with Activation of Apoptotic Pathways: Studies in a Model of Suppressed Thrombopoiesis in Dogs , 2002, Thrombosis and Haemostasis.

[62]  M. Luca,et al.  α-Secretase ADAM10 as Well as αAPPs Is Reduced in Platelets and CSF of Alzheimer Disease Patients , 2002, Molecular medicine.

[63]  L. Corcos,et al.  Early increase in DcR2 expression and late activation of caspases in the platelet storage lesion , 2001, Leukemia.

[64]  L. Barbeito,et al.  The molecular bases of Alzheimer's disease and other neurodegenerative disorders. , 2001, Archives of medical research.

[65]  D. M. Skovronsky,et al.  Amyloid Precursor Protein and Amyloid β Peptide in Human Platelets , 2001, The Journal of Biological Chemistry.

[66]  B. Zlokovic,et al.  beta-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1. , 2000, American journal of physiology. Cell physiology.

[67]  B. Borroni,et al.  Presenilin 2 Mutation Does Not Influence Expression and Concentration of APP Forms in Human Platelets , 2000, Molecular medicine.

[68]  M. Luca,et al.  Platelets as a peripheral district where to study pathogenetic mechanisms of alzheimer disease: the case of amyloid precursor protein. , 2000, European journal of pharmacology.

[69]  A. Doig,et al.  Inhibition of Toxicity in the β-Amyloid Peptide Fragment β-(25–35) Using N-Methylated Derivatives , 2000, The Journal of Biological Chemistry.

[70]  R. Rosenberg,et al.  Platelet APP isoform ratios correlate with declining cognition in AD , 2000, Neurology.

[71]  D. Cribbs,et al.  β amyloid fragments derived from activated platelets deposit in cerebrovascular endothelium : Usage of a novel blood brain barrier endothelial cell model system , 2000, Neurobiology of Aging.

[72]  L. Alberio,et al.  Surface expression and functional characterization of alpha-granule factor V in human platelets: effects of ionophore A23187, thrombin, collagen, and convulxin. , 2000, Blood.

[73]  J. Savill,et al.  Constitutive Death of Platelets Leading to Scavenger Receptor-mediated Phagocytosis , 2000, The Journal of Biological Chemistry.

[74]  D. Cribbs,et al.  β amyloid fragments derived from activated platelets deposit in cerebrovascular endothelium: Usage of a novel blood brain barrier endothelial cell model system , 2000 .

[75]  J. Hartwig,et al.  Blood Platelets Are Assembled Principally at the Ends of Proplatelet Processes Produced by Differentiated Megakaryocytes , 1999, The Journal of cell biology.

[76]  M. Bryckaert,et al.  Regulation of c-jun-NH2 terminal kinase and extracellular-signal regulated kinase in human platelets. , 1999, Blood.

[77]  C. Masters,et al.  The amyloid precursor protein of Alzheimer disease in human brain and blood , 1999, Journal of leukocyte biology.

[78]  J. Gomez-Fernandez,et al.  Structure of the Alzheimer beta-amyloid peptide (25-35) and its interaction with negatively charged phospholipid vesicles. , 1999, European journal of biochemistry.

[79]  D. Green,et al.  Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation. , 1999, Blood.

[80]  C. Masters,et al.  Inhibition of platelet activation by the Alzheimer's disease amyloid precursor protein , 1998, British journal of haematology.

[81]  E. Mandelkow,et al.  Tau in Alzheimer's disease. , 1998, Trends in cell biology.

[82]  A. Placzek,et al.  Alzheimer's β-amyloid peptides induce inflammatory cascade in human vascular cells: the roles of cytokines and CD40 , 1998, Brain Research.

[83]  L. Vignolo,et al.  Differential level of platelet amyloid beta precursor protein isoforms: an early marker for Alzheimer disease. , 1998, Archives of neurology.

[84]  L. Horstman,et al.  Platelet activation in Alzheimer disease. , 1998, Archives of neurology.

[85]  K. Beyreuther,et al.  Secretion of Alzheimer's disease Abeta amyloid peptide by activated human platelets. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[86]  Jeffrey C. Erlich,et al.  Phospholipid‐Metabolizing Enzymes in Alzheimer's Disease: Increased Lysophospholipid Acyltransferase Activity and Decreased Phospholipase A2 Activity , 1998, Journal of neurochemistry.

[87]  Christopher C. T Smith,et al.  Stimulated release of the β-amyloid protein of Alzheimer's disease by normal human platelets , 1997, Neuroscience Letters.

[88]  J. Morris,et al.  Current concepts in the pathogenesis of Alzheimer's disease. , 1997, The American journal of medicine.

[89]  M. Klinger.  Platelets and inflammation , 1997, Anatomy and Embryology.

[90]  A. Billingslea,et al.  Activated Alzheimer Disease Platelets Retain More Beta Amyloid Precursor Protein , 1997, Neurobiology of Aging.

[91]  L. Honig,et al.  Altered amyloid protein processing in platelets of patients with Alzheimer disease. , 1997, Archives of neurology.

[92]  Y. Suh,et al.  Ionic effects of the Alzheimer's disease β-amyloid precursor protein and its metabolic fragments , 1997, Trends in Neurosciences.

[93]  M. Luca,et al.  Abnormal pattern of platelet APP isoforms in Alzheimer disease and Down syndrome. , 1996, Archives of neurology.

[94]  P. Kinnunen,et al.  Activation of phospholipase A2 by amyloid beta-peptides in vitro. , 1996, Biochemistry.

[95]  M. Mullan,et al.  β-Amyloid-mediated vasoactivity and vascular endothelial damage , 1996, Nature.

[96]  R. Petersen,et al.  Plasma catechols and monoamine oxidase metabolites in untreated Parkinson's and Alzheimer's diseases , 1996, Journal of the Neurological Sciences.

[97]  A. Schmaier,et al.  Protease Nexin-2/Amyloid β-Protein Precursor Inhibits Factor Xa in the Prothrombinase Complex (*) , 1995, The Journal of Biological Chemistry.

[98]  L. Iversen,et al.  The toxicity in vitro of beta-amyloid protein. , 1995, The Biochemical journal.

[99]  N. Inestrosa,et al.  Platelets Are the Primary Source of Amyloid β-Peptide in Human Blood , 1995 .

[100]  C. Masters,et al.  Proteolytic Processing of Alzheimer's Disease βA4 Amyloid Precursor Protein in Human Platelets (*) , 1995, The Journal of Biological Chemistry.

[101]  T. Taniguchi,et al.  Alteration of Phospholipase C‐δ Protein Level and Specific Activity in Alzheimer's Disease , 1995 .

[102]  S. Shimohama,et al.  Reduction of Platelet Phospholipase C Activity in Patients with Alzheimer Disease , 1995, Alzheimer disease and associated disorders.

[103]  M. Mattson.  Calcium and Neuronal Injury in Alzheimer's Disease , 1994, Annals of the New York Academy of Sciences.

[104]  C. Masters,et al.  Membrane-associated forms of the beta A4 amyloid protein precursor of Alzheimer's disease in human platelet and brain: surface expression on the activated human platelet. , 1994, Blood.

[105]  J. Seelig,et al.  Alzheimer beta-amyloid peptide 25-35: electrostatic interactions with phospholipid membranes. , 1994, Biochemistry.

[106]  C. J. Moore,et al.  Phospholipase A2 activation influences the processing and secretion of the amyloid precursor protein. , 1993, Biochemical and biophysical research communications.

[107]  M. Pericak-Vance,et al.  Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[108]  S. Younkin,et al.  Production of Amyloid β Protein from Normal Amyloid β‐Protein Precursor (βAPP) and the Mutated βAPPS Linked to Familial Alzheimer's Disease a , 1993 .

[109]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[110]  A. Schmaier,et al.  Potential Role of Protease Nexin‐2/Amyloid β‐Protein Precursor as a Cerebral Anticoagulant a , 1992 .

[111]  C. Masters,et al.  The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth , 1992, Neuron.

[112]  M. Mesulam,et al.  β-Amyloid and the pathogenesis of alzheimer's disease , 1991 .

[113]  P. Whitehouse,et al.  Intracellular membranes are more fluid in platelets of Alzheimer's disease patients , 1991, Neurobiology of Aging.

[114]  I. Teply,et al.  Risk factors for stroke as predictors of platelet membrane fluidity in Alzheimer's disease. , 1991, Stroke.

[115]  H. Meltzer,et al.  Serotonin uptake in the blood platelets of Alzheimer's disease patients , 1991, Neurology.

[116]  K. Davis,et al.  Platelet phospholipid synthesis in Alzheimer's disease , 1991, Neurobiology of Aging.

[117]  J. Ghiso,et al.  Intact Alzheimer amyloid precursor protein (APP) is present in platelet membranes and is encoded by platelet mRNA. , 1990, Biochemical and biophysical research communications.

[118]  R. Martins,et al.  The amyloid precursor protein of Alzheimer's disease is released by human platelets. , 1990, The Journal of biological chemistry.

[119]  R. Levy,et al.  Platelet and erythrocyte membrane changes in Alzheimer's disease. , 1990, Biochimica et biophysica acta.

[120]  J. Nalbantoglu,et al.  Genetic Factors in Alzheimer's Disease , 1990, Journal of the American Geriatrics Society.

[121]  S. Younkin,et al.  Expression of β amyloid protein precursor mRNAs: Recognition of a novel alternatively spliced form and quantitation in alzheimer's disease using PCR , 1990, Neuron.

[122]  M. Kroll,et al.  Biochemical mechanisms of platelet activation. , 1989, Blood.

[123]  Andreas Weidemann,et al.  Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein , 1989, Cell.

[124]  D. Selkoe,et al.  Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[125]  S. Shiojiri,et al.  Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity , 1988, Nature.

[126]  L. Villa-komaroff,et al.  Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease , 1988, Nature.

[127]  F. Boller,et al.  Platelet membrane abnormality in Alzheimer's disease , 1987, Annals of neurology.

[128]  B. Cohen,et al.  Abnormal platelet membrane composition in Alzheimer's-type dementia. , 1987, Life sciences.

[129]  Y. Michotte,et al.  Distribution of biogenic amines and their catabolites in brains from patients with Alzheimer's disease , 1987, Journal of the Neurological Sciences.

[130]  K. Grzeschik,et al.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.

[131]  D. Neary,et al.  Presynaptic Serotonergic Dysfunction in Patients with Alzheimer's Disease , 1987, Journal of neurochemistry.

[132]  N. Nair,et al.  Platelet 3H-imipramine binding distinguishes depression from Alzheimer dementia. , 1985, Life sciences.

[133]  S. Heptinstall,et al.  The effects of PGE2 and CL 115,347, an antihypertensive PGE2 analogue, on human blood platelet behaviour and vascular contractility. , 1985, European journal of pharmacology.

[134]  J. Wikström,et al.  Uptake of 5-hydroxytryptamine by blood platelets in Huntington's chorea and Alzheimer type of presenile dementia. , 1981, Medical biology.

[135]  B. Winblad,et al.  Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type. , 1980, Life sciences.

[136]  Jonathan E. Hempel,et al.  Chemical Biology , 2015, Methods in Molecular Biology.

[137]  A. Bacci,et al.  Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease , 2011, Nature Neuroscience.

[138]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[139]  N. Pivac,et al.  Platelet serotonin and monoamine oxidase in Alzheimer's disease with psychotic features. , 2008, Collegium antropologicum.

[140]  D. Craig,et al.  Platelet beta-secretase activity is increased in Alzheimer's disease. , 2008, Neurobiology of aging.

[141]  T. Casoli,et al.  Release of beta-amyloid from high-density platelets: implications for Alzheimer's disease pathology. , 2007, Annals of the New York Academy of Sciences.

[142]  R. Levy,et al.  Decreased phospholipase A2 activity in the brain and in platelets of patients with Alzheimer's disease , 2005, European Archives of Psychiatry and Clinical Neuroscience.

[143]  N. Pivac,et al.  Platelet serotonin and monoamine oxidase activity in patients with early-onset and late-onset of Alzheimer's disease , 2005 .

[144]  H. Cai,et al.  Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[145]  O. Forlenza,et al.  Platelet phospholipase A(2) activity in Alzheimer's disease and mild cognitive impairment. , 2004, Journal of neural transmission.

[146]  Rena Li,et al.  Amyloid (cid:1) peptide load is correlated with increased (cid:1) -secretase activity in sporadic Alzheimer’s disease patients , 2004 .

[147]  H. Hampel,et al.  Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. , 2003, Annals of neurology.

[148]  R. Pluta.  Blood-brain barrier dysfunction and amyloid precursor protein accumulation in microvascular compartment following ischemia-reperfusion brain injury with 1-year survival. , 2003, Acta neurochirurgica. Supplement.

[149]  C. Caltagirone,et al.  Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease. , 2002, Archives of neurology.

[150]  A. Doig,et al.  Inhibition of toxicity in the beta-amyloid peptide fragment beta -(25-35) using N-methylated derivatives: a general strategy to prevent amyloid formation. , 2000, The Journal of biological chemistry.

[151]  J. Balsinde,et al.  Regulation and inhibition of phospholipase A2. , 1999, Annual review of pharmacology and toxicology.

[152]  E. Remold-O’Donnell,et al.  HEMOSTASIS , THROMBOSIS , AND VASCULAR BIOLOGY Role of Caspase in a Subset of Human Platelet Activation Responses , 1999 .

[153]  S. Shimohama,et al.  Reduction of platelet phospholipase C-delta1 activity in Alzheimer's disease associated with a specific apolipoprotein E genotype (epsilon3/epsilon3). , 1998, International journal of molecular medicine.

[154]  J. Kornhuber,et al.  Improved electrophoretic separation and immunoblotting of beta‐amyloid (Aβ) peptides 1–40, 1–42, and 1–43 , 1997, Electrophoresis.

[155]  M. Mullan,et al.  beta-Amyloid-mediated vasoactivity and vascular endothelial damage. , 1996, Nature.

[156]  T. Taniguchi,et al.  Alteration of phospholipase C-delta protein level and specific activity in Alzheimer's disease. , 1995, Journal of neurochemistry.

[157]  N. Inestrosa,et al.  Platelets are the primary source of amyloid beta-peptide in human blood. , 1995, Biochemical and biophysical research communications.

[158]  S. Younkin,et al.  Production of amyloid beta protein from normal amyloid beta-protein precursor (beta APP) and the mutated beta APPS linked to familial Alzheimer's disease. , 1993, Annals of the New York Academy of Sciences.

[159]  A. Schmaier,et al.  Potential role of protease nexin-2/amyloid beta-protein precursor as a cerebral anticoagulant. , 1992, Annals of the New York Academy of Sciences.

[160]  K. Grzeschik,et al.  The precursor of Alzheimer??s disease amyloid A4 protein resembles a cell-surface receptor , 1987 .

[161]  A. Alzheimer.  Uber eine eigenartige Erkrankung der Hirnrinde , 1907 .